Invention Grant
- Patent Title: Combination formulation of three antiviral compounds
-
Application No.: US16306424Application Date: 2017-06-01
-
Publication No.: US11338007B2Publication Date: 2022-05-24
- Inventor: Ben Chal , Elham Nejati , Rowchanak Pakdaman , Dimitrios Stefanidis
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agency: Sheppard Mullin Richter & Hampton LLP
- International Application: PCT/US2017/035539 WO 20170601
- International Announcement: WO2017/210483 WO 20171207
- Main IPC: A61K38/06
- IPC: A61K38/06 ; A61K9/20 ; A61K31/4188 ; A61K31/7072 ; A61K31/4985 ; A61K9/14 ; A61K31/4178 ; A61K47/32 ; A61K47/38 ; A61K9/16
Abstract:
Disclosed are pharmaceutical compositions comprising three antiviral compounds. In particular, the pharmaceutical compositions comprise an effective amount of velpatasvir, an effective amount of sofosbuvir, and an effective amount of voxilaprevir. Also disclosed are methods of use for the pharmaceutical composition.
Public/Granted literature
- US20200323894A1 COMBINATION FORMULATION OF THREE ANTIVIRAL COMPOUNDS Public/Granted day:2020-10-15
Information query
IPC分类:
